Selected article for: "coronavirus infection and immune system"
Author: Guo, Qirui; Zhao, Yingchi; Li, Junhong; Liu, Jiangning; Guo, Xuefei; Zhang, Zeming; Cao, Lili; Luo, Yujie; Bao, Linlin; Wang, Xiao; Wei, Xuemei; Deng, Wei; Chen, Luoying; Zhu, Hua; Gao, Ran; Qin, Chuan; Wang, Xiangxi; You, Fuping
Title: Small molecules inhibit SARS-COV-2 induced aberrant inflammation and viral replication in mice by targeting S100A8/A9-TLR4 axis
  • Cord-id: 1b6sycgv
  • Document date: 2020_9_9
    • ID: 1b6sycgv
    Snippet: The SARS-CoV-2 pandemic poses an unprecedented public health crisis. Accumulating evidences suggest that SARS-CoV-2 infection causes dysregulation of immune system. However, the unique signature of early immune responses remains elusive. We characterized the transcriptome of rhesus macaques and mice infected with SARS-CoV-2. Alarmin S100A8 was robustly induced by SARS-CoV-2 in animal models as well as in COVID-19 patients. Paquinimod, a specific inhibitor of S100A8/A9, could reduce inflammatory
    Document: The SARS-CoV-2 pandemic poses an unprecedented public health crisis. Accumulating evidences suggest that SARS-CoV-2 infection causes dysregulation of immune system. However, the unique signature of early immune responses remains elusive. We characterized the transcriptome of rhesus macaques and mice infected with SARS-CoV-2. Alarmin S100A8 was robustly induced by SARS-CoV-2 in animal models as well as in COVID-19 patients. Paquinimod, a specific inhibitor of S100A8/A9, could reduce inflammatory response and rescue the pneumonia with substantial reduction of viral titers in SASR-CoV-2 infected animals. Remarkably, Paquinimod treatment resulted in 100% survival of mice in a lethal model of mouse coronavirus (MHV) infection. A novel group of neutrophils that contributed to the uncontrolled inflammation and onset of COVID-19 were dramatically induced by coronavirus infections. Paquinimod treatment could reduce these neutrophils and regain antiviral responses, unveiling key roles of S100A8/A9 and noncanonical neutrophils in the pathogenesis of COVID-19, highlighting new opportunities for therapeutic intervention.

    Search related documents:
    Co phrase search for related documents
    • abnormal cell and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • abnormal cell number and acute respiratory syndrome: 1
    • abnormal immune response and activation response: 1
    • abnormal immune response and acute respiratory syndrome: 1, 2, 3, 4, 5
    • abnormal immune response and low quality: 1
    • abnormal inflammation and acute ards respiratory distress syndrome: 1, 2, 3
    • abnormal inflammation and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8
    • abnormal neutrophil and acute respiratory syndrome: 1, 2, 3
    • accumulate evidence and acute respiratory syndrome: 1
    • activation response and acute ards respiratory distress syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21
    • activation response and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • activation response and adaptor protein: 1, 2, 3, 4
    • acute ards respiratory distress syndrome and adaptor protein: 1
    • acute respiratory syndrome and adaptor protein: 1, 2, 3, 4, 5
    • acute respiratory syndrome and adhesion neutrophil chemotaxis: 1, 2